
Please try another search
On today’s episode of the Tech Talk Tuesday podcast, Ryan McQueeney discusses one of the trendiest bitcoin-related companies, Riot Blockchain (NASDAQ:RIOT) , and why short-selling firm Citron Research decided to short the stock.
Remember to subscribe and leave a rating on iTunes if you enjoy the show!
Before jumping into the crypto-craziness that is Riot Blockchain, Ryan provides a basic introduction to the cryptocurrency market, including the definition of key terms like “blockchain” and “mining.”
Once the basics are out of the way, Ryan dives into Riot, starting with its recent name change. That’s right, up until a few months ago, this red-hot stock was actually a dying biotech equipment manufacturer called “Bioptix.”
After a failed acquisition left Biotix bleeding cash, its CEO decided to shift the company’s focus. Now, the firm operates its own bitcoin mining operation and boasts investments in several cryptocurrency and blockchain-focused companies.
However, shares of Riot have soared over 400% within the past month alone, despite serious concerns about the company’s lack of revenue, mounting debt, and unclear business model.
These concerns were exacerbated on Monday when Riot found itself in the crosshairs of famed short-seller Citron Research.
Ryan discusses all of the latest Riot news and explains why Citron is touching on some important points.
Make sure to tune into the show to hear more!
As a reminder, if you feel that we missed something, or if you want us to cover a different story, shoot us an email at podcast@zacks.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating on iTunes.
As always, thanks for listening to the Zacks Tech Talk Tuesday Podcast; we will see you next time!
Want more stock market analysis from this author? Make sure to follow @Ryan_McQueeney on Twitter!
Zacks Editor-in-Chief Goes "All In" on This Stock
Full disclosure, Kevin Matras now has more of his own money in one particular stock than in any other. He believes in its short-term profit potential and also in its prospects to more than double by 2019. Today he reveals and explains his surprising move in a new Special Report.
The markets have been sluggish this week as investors hope for a jolt later in the week when AI juggernaut NVIDIA Corporation (NASDAQ:NVDA) reports fourth quarter and year-end...
On Friday, a wave of selling pressure swept across the US equity markets, leaving a trail of losses. The S&P 500 closed down 1.7%, the DOW slid 1.69%, and the NASDAQ tumbled a...
Palantir remains highly valued with a 460x P/E ratio and a 42.5x P/B ratio, far above its peers. The stock's beta of 2.81 signals high volatility, meaning sharp moves in both...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.